drugset / Trial / NCT06529419

A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations

NCT06529419 ↗

Phase 2 Completed 537 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A dose range-finding study to assess the efficacy and safety of multiple dose levels of AZD8630 administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA).

Timeline

Start
2024-08-30
Primary completion
2026-02-04
Completion
2026-02-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD8630 Unknown — Inhaled

Indications